510(k) device
Aliya(TM) System, Aliya(TM) Generator, Aliya(TM) Needle, Aliya(TM) Electrode
Galvanize Therapeutics, Inc. · Low Energy Direct Current Thermal Ablation System (OAB, Class II) · First FDA decision Jun 17, 2022, newest Jun 17, 2022Tumor ablation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
7
Naming "Aliya"
MAUDE reports
7
Brand "Aliya", since 2015
PubMed studies
23
Mentioning "Aliya"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Aliya(TM) System, Aliya(TM) Generator, Aliya(TM) Needle, Aliya(TM) Electrode
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K212871 · Decided Jun 17, 2022 · 281 days after receipt
Device type: Low Energy Direct Current Thermal Ablation System (OAB) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Aliya", any status and sponsor, newest update first.
University of California, San FranciscoAcademic, hospital or other
NCT07487844 · 20 participants (planned) · Start Jun 29, 2026 · Primary completion Dec 31, 2028
Device: Pulsed Electric Field (PEF) System · For: Metastatic Breast Cancer; Breast Cancer
Sites: San Francisco, California
Galvanize Therapeutics, Inc.Not on our public-company list
NCT05851430 · 1,000 participants (planned) · Start Jun 23, 2025 · Primary completion Jun 30, 2028
Device: PEF ablation · For: Soft Tissue Lesion
Sites: Gilbert, Arizona; Rancho Mirage, California; Naples, Florida · 11 sites in all
Galvanize Therapeutics, Inc.Not on our public-company list
NCT07487064 · 25 participants (planned) · Start Mar 13, 2026 · Primary completion Jan 31, 2027
Device: Aliya Pulsed Electric Field (PEF) · For: Lung Cancer
Sites: Shatin, Hong Kong
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Aliya", and for the whole product code for context.
This brand
7 reports: 0 malfunction, 7 injury, 0 death
Whole product code OAB
114 reports: 47 malfunction, 59 injury, 8 death
Newest reports for this brand
- AliyaInjury
3017185164-2026-00004 · Received Sep 18, 2026 · Event dated Feb 15, 2024
Device type: Low Energy Direct Current Thermal Ablation System (OAB)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Pneumothorax
- AliyaInjury
3017185164-2026-00005 · Received Sep 18, 2026 · Event dated Feb 16, 2024
Device type: Low Energy Direct Current Thermal Ablation System (OAB)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Pneumothorax
- AliyaInjury
3017185164-2026-00003 · Received Sep 10, 2026 · Event dated Jul 7, 2025
Device type: Low Energy Direct Current Thermal Ablation System (OAB)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Pneumothorax
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Aliya"[tiab]. The summary above synthesizes these.
- SOGC Guideline Retirement Notice No. 1.
J Obstet Gynaecol Can · 2022
- Pulsed electric field ablation safety and characterization near sensitive structures in lung: a preclinical and clinical case series study.
Hunter DW, Krimsky W, Meyerhoff RR, et al. · J Thorac Dis · 2025
- Dentition of the Mugharet El'Aliya Fossil Human Maxilla, Morocco.
Röding C, El-Zaatari S, Ramirez Rozzi FV, et al. · Am J Biol Anthropol · 2025Research Support, Non-U.S. Gov't
- Pulsed Electrical Field Ablation Plus Intratumoral Immunotherapy for Hepatocellular Carcinoma.
Soule E, Vargas C, Sanchez R, et al. · J Immunother · 2026
- Tissue Radiologic and Pathologic Response to Biphasic Pulsed Electric Field Technology in a Porcine Model.
Kaviani R, Neal RE, Hunter DW, et al. · J Vasc Interv Radiol · 2024Research Support, Non-U.S. Gov't
- Characteristics of pulsed electric field cardiac ablation porcine treatment zones with a focal catheter.
Verma A, Neal R, Evans J, et al. · J Cardiovasc Electrophysiol · 2023Research Support, Non-U.S. Gov't
- Reexamination of the immature hominid maxilla from Tangier, Morocco.
Minugh-Purvis N · Am J Phys Anthropol · 1993Comparative Study, Historical Article
- The Safety of Pulsed Electric Field Ablation Before Standard of Care Treatment for Patients With Metastatic Cancer.
Pritchett MA, Reisenauer JS, Fernandez-Bussy S, et al. · J Bronchology Interv Pulmonol · 2025
- Understanding the aliya pulsed electric field dose-response relationship: Implications for ablation size, thermal load, and immune response in an orthotopic murine breast cancer model.
Nafie EHO, Pastori C, Acharya R, et al. · PLoS One · 2025Research Support, Non-U.S. Gov't
- Six-Month Local Control Rates and Immune Responses After Pulsed Electric Field Ablation in Metastatic Cancer.
Moreno-Gonzalez A, Nafie EHO, Pastori C, et al. · Cancers (Basel) · 2025
- Healing spirits of South Kanara.
Shields NK · Cult Med Psychiatry · 1987Research Support, Non-U.S. Gov't
- Pulsed Electric Field (PEF) treatment of progressive non-small cell lung cancer concurrently treated with immune checkpoint blockade: A case report.
Jimenez M, Fernandez JM, Krimsky WS · Respir Med Case Rep · 2024Case Reports
Other devices of this type
Also filed under product code OAB.
- NanoKnife Generator (H78720300351US0)Angiodynamics · 510(k) 2026
- Oncobionic System with 6 Probe OutputOncobionics, Inc. · 510(k) 2008
- Steep Pulse Ablation Instrument (including Disposable Sterile Steep Pulse Probe) (SPA-C02)Hangzhou Ruidi Biotechnology , Ltd. · 510(k) 2026
- Aliya® EX SystemGalvanize Therapeutics, Inc. · 510(k) 2026
- Electroporation System (N3000)Surgnova Healthcare Technologies (Zhejiang) Co., Ltd. · 510(k) 2024
- INUMI Flex NeedleGalvanize Therapeutics, Inc. · 510(k) 2024
- Canady Helios Cold Plasma XL-1000CP Ablation System (XL-1000CPSYS)Us Medical Innovations, LLC · 510(k) 2024
- Irreversible Electroporation Ablation GeneratorZhejiang Curaway Medical Technology Co., Ltd. · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.